Camp4 Therapeutics CAMP Stock
Camp4 Therapeutics Price Chart
Camp4 Therapeutics CAMP Financial and Trading Overview
Camp4 Therapeutics stock price | 3.09 USD |
Previous Close | 1.74 USD |
Open | 1.76 USD |
Bid | 1.75 USD x 800 |
Ask | 1.82 USD x 1100 |
Day's Range | 1.73 - 1.84 USD |
52 Week Range | 1.61 - 7.25 USD |
Volume | 229.36K USD |
Avg. Volume | 156.16K USD |
Market Cap | 68.86M USD |
Beta (5Y Monthly) | 2.005985 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -11.04 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.44 USD |
CAMP Valuation Measures
Enterprise Value | 268.51M USD |
Trailing P/E | N/A |
Forward P/E | 4.27907 |
PEG Ratio (5 yr expected) | 0.57 |
Price/Sales (ttm) | 0.23347026 |
Price/Book (mrq) | 4.8041778 |
Enterprise Value/Revenue | 0.91 |
Enterprise Value/EBITDA | 161.851 |
Trading Information
Camp4 Therapeutics Stock Price History
Beta (5Y Monthly) | 2.005985 |
52-Week Change | -69.58% |
S&P500 52-Week Change | 20.43% |
52 Week High | 7.25 USD |
52 Week Low | 1.61 USD |
50-Day Moving Average | 2.19 USD |
200-Day Moving Average | 3.61 USD |
CAMP Share Statistics
Avg. Volume (3 month) | 156.16K USD |
Avg. Daily Volume (10-Days) | 181.79K USD |
Shares Outstanding | 37.42M |
Float | 30.43M |
Short Ratio | 5.55 |
% Held by Insiders | 5.56% |
% Held by Institutions | 71.79% |
Shares Short | 742.23K |
Short % of Float | 2.50% |
Short % of Shares Outstanding | 1.98% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | February 28, 2023 |
Most Recent Quarter (mrq) | February 28, 2023 |
Next Fiscal Year End | February 28, 2024 |
Profitability
Profit Margin | -11.015% |
Operating Margin (ttm) | -6.81% |
Gross Margin | 36.95% |
EBITDA Margin | 0.56% |
Management Effectiveness
Return on Assets (ttm) | -3.25% |
Return on Equity (ttm) | -72.43% |
Income Statement
Revenue (ttm) | 294.95M USD |
Revenue Per Share (ttm) | 8.16 USD |
Quarterly Revenue Growth (yoy) | 14.79% |
Gross Profit (ttm) | N/A |
EBITDA | 1.66M USD |
Net Income Avi to Common (ttm) | -32490000 USD |
Diluted EPS (ttm) | -0.88 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 41.93M USD |
Total Cash Per Share (mrq) | 1.12 USD |
Total Debt (mrq) | 245.32M USD |
Total Debt/Equity (mrq) | 1714.68 USD |
Current Ratio (mrq) | 1.641 |
Book Value Per Share (mrq) | 0.383 |
Cash Flow Statement
Operating Cash Flow (ttm) | -22932000 USD |
Levered Free Cash Flow (ttm) | -7032375 USD |
Profile of Camp4 Therapeutics
Country | United States |
State | CA |
City | Irvine |
Address | 15635 Alton Parkway |
ZIP | 92618 |
Phone | 949 600 5600 |
Website | https://www.calamp.com |
Industry | Communication Equipment |
Sector(s) | Technology |
Full Time Employees | 644 |
CalAmp Corp., a connected intelligence company, provides leverages a data-driven solutions ecosystem to people and organizations in the United States, Europe, the Middle East, Africa, Latin America, the Asia-Pacific, and internationally. The company operates in two segments, Software & Subscription Services and Telematics Products. It provides CalAmp Telematics Cloud platform, such as cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open application programming interfaces; and software as a service application, as well as provides tracking and monitoring services within fleet management, supply chain integrity, and international vehicle location. The company also offers telematics products, including asset tracking units, mobile telematics devices, fixed and mobile wireless gateways, and routers; and advanced telematics products for the broader connected vehicle and Internet of Things marketplace, which enable customers to optimize their operations by collecting, monitoring, and reporting business-critical information and desired intelligence from remote and mobile assets. In addition, it offers professional services, including project management, engineering services, and installation services. The company sells its products and services to customers in the automotive, telecommunications, industrial equipment, transportation and logistics, government and municipalities, insurance, original equipment manufacturers, and leasing companies. It markets through direct sales organization, channel partner program, original equipment manufacturers, and independent sales representatives and distributors, as well as its websites and digital platform. The company was incorporated in 1981 and is headquartered in Irvine, California.
Q&A For Camp4 Therapeutics Stock
What is a current CAMP stock price?
Camp4 Therapeutics CAMP stock price today per share is 3.09 USD.
How to purchase Camp4 Therapeutics stock?
You can buy CAMP shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Camp4 Therapeutics?
The stock symbol or ticker of Camp4 Therapeutics is CAMP.
Which industry does the Camp4 Therapeutics company belong to?
The Camp4 Therapeutics industry is Communication Equipment.
How many shares does Camp4 Therapeutics have in circulation?
The max supply of Camp4 Therapeutics shares is 20.16M.
What is Camp4 Therapeutics Price to Earnings Ratio (PE Ratio)?
Camp4 Therapeutics PE Ratio is now.
What was Camp4 Therapeutics earnings per share over the trailing 12 months (TTM)?
Camp4 Therapeutics EPS is -11.04 USD over the trailing 12 months.
Which sector does the Camp4 Therapeutics company belong to?
The Camp4 Therapeutics sector is Technology.
Camp4 Therapeutics CAMP included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
NASDAQ Telecommunications IXTC | 484.77 USD — |
-3.01
|
— — | 484.41 USD — | 497.66 USD — | — - | — — |
NASDAQ Global Select Market Com NQGS | 8098.63 USD — |
-5.98
|
— — | 8089.65 USD — | 8265.47 USD — | — - | — — |
NASDAQ Composite Total Return I XCMP | 20257.83 USD — |
-5.96
|
— — | 20236.33 USD — | 20672.41 USD — | — - | — — |
- {{ link.label }} {{link}}